Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2004 1
2005 2
2012 1
2013 1
2017 1
2018 2
2020 2
2021 2
2022 7
2023 5
2024 2
2025 3

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

26 results

Results by year

Filters applied: . Clear all
Page 1
Autoantibodies against the chemokine receptor 3 predict cardiovascular risk.
Müller FS, Aherrahrou Z, Grasshoff H, Heidorn MW, Humrich JY, Johanson L, Aherrahrou R, Reinberger T, Schulz A, Ten Cate V, Robles AP, Koeck T, Rapp S, Lange T, Brachaczek L, Luebber F, Erdmann J, Heidecke H, Schulze-Forster K, Dechend R, Lackner KJ, Pfeiffer N, Ghaemi Kerahrodi J, Tüscher O, Schwarting A, Strauch K, Münzel T, Prochaska JH, Riemekasten G, Wild PS. Müller FS, et al. Among authors: schulze forster k. Eur Heart J. 2023 Dec 14;44(47):4935-4949. doi: 10.1093/eurheartj/ehad666. Eur Heart J. 2023. PMID: 37941454 Free PMC article.
Identification of novel autoantibodies in Sjögren's disease.
Engelke F, Budde P, De Vita S, Dörner T, Ernst D, Gras J, Heidecke H, Kilian AL, Kniesch K, Lindemann AS, Quartuccio L, Ritter J, Schulze-Forster K, Seeliger B, Zucht HD, Witte T. Engelke F, et al. Among authors: schulze forster k. Front Immunol. 2025 Feb 3;16:1524940. doi: 10.3389/fimmu.2025.1524940. eCollection 2025. Front Immunol. 2025. PMID: 39963128 Free PMC article.
Induced antibodies directed to the angiotensin receptor type 1 provoke skin and lung inflammation, dermal fibrosis and act species overarching.
Yue X, Yin J, Wang X, Heidecke H, Hackel AM, Dong X, Kasper B, Wen L, Zhang L, Schulze-Forster K, Junker J, Grasshoff H, Müller A, Wallukat G, Schimke I, Zeiner J, Deckstein LM, Mertens N, Kerstein-Staehle A, Hundt JE, Kostenis E, Yu X, Riemekasten G, Petersen F. Yue X, et al. Among authors: schulze forster k. Ann Rheum Dis. 2022 Aug 11;81(9):1281-1289. doi: 10.1136/annrheumdis-2021-222088. Ann Rheum Dis. 2022. PMID: 35595388 Free PMC article.
Autoantibodies targeting GPCRs and RAS-related molecules associate with COVID-19 severity.
Cabral-Marques O, Halpert G, Schimke LF, Ostrinski Y, Vojdani A, Baiocchi GC, Freire PP, Filgueiras IS, Zyskind I, Lattin MT, Tran F, Schreiber S, Marques AHC, Plaça DR, Fonseca DLM, Humrich JY, Müller A, Giil LM, Graßhoff H, Schumann A, Hackel A, Junker J, Meyer C, Ochs HD, Lavi YB, Scheibenbogen C, Dechend R, Jurisica I, Schulze-Forster K, Silverberg JI, Amital H, Zimmerman J, Heidecke H, Rosenberg AZ, Riemekasten G, Shoenfeld Y. Cabral-Marques O, et al. Among authors: schulze forster k. Nat Commun. 2022 Mar 9;13(1):1220. doi: 10.1038/s41467-022-28905-5. Nat Commun. 2022. PMID: 35264564 Free PMC article.
Protease-Activated Receptor-1 IgG Autoantibodies in Patients with COVID-19.
Reinshagen L, Nageswaran V, Heidecke H, Schulze-Forster K, Wilde AB, Ramezani Rad P, Poller W, Asmus E, Simmons S, Kuebler WM, Witzenrath M, Markó L, Jakobs K, Puccini M, Leistner DM, Rauch-Kröhnert U, Kränkel N, Forslund SK, Landmesser U, Müller DN, Haghikia A. Reinshagen L, et al. Among authors: schulze forster k. Thromb Haemost. 2024 Dec;124(12):1164-1166. doi: 10.1055/a-2205-0014. Epub 2023 Nov 6. Thromb Haemost. 2024. PMID: 37931906 No abstract available.
Autoantibodies targeting G protein-coupled receptors: An evolving history in autoimmunity. Report of the 4th international symposium.
Cabral-Marques O, Moll G, Catar R, Preuß B, Bankamp L, Pecher AC, Henes J, Klein R, Kamalanathan AS, Akbarzadeh R, van Oostveen W, Hohberger B, Endres M, Koolmoes B, Levarht N, Postma R, van Duinen V, van Zonneveld AJ, de Vries-Bouwstra J, Fehres C, Tran F, do Vale FYN, da Silva Souza KB, Filgueiras IS, Schimke LF, Baiocchi GC, de Miranda GC, da Fonseca DLM, Freire PP, Hackel AM, Grasshoff H, Stähle A, Müller A, Dechend R, Yu X, Petersen F, Sotzny F, Sakmar TP, Ochs HD, Schulze-Forster K, Heidecke H, Scheibenbogen C, Shoenfeld Y, Riemekasten G. Cabral-Marques O, et al. Among authors: schulze forster k. Autoimmun Rev. 2023 May;22(5):103310. doi: 10.1016/j.autrev.2023.103310. Epub 2023 Mar 10. Autoimmun Rev. 2023. PMID: 36906052 Review.
Increased protease-activated receptor 1 autoantibodies are associated with severe COVID-19.
Tran F, Harris DMM, Scharmacher A, Graßhoff H, Sterner K, Schinke S, Käding N, Humrich JY, Cabral-Marques O, Bernardes JP, Mishra N, Bahmer T, Franzenburg J, Hoyer BF, Glück A, Guggeis M, Ossysek A, Küller A, Frank D, Lange C, Rupp J, Heyckendorf J, Gaede KI, Amital H, Rosenstiel P, Shoenfeld Y, Halpert G, Rosenberg AZ, Schulze-Forster K, Heidecke H, Riemekasten G, Schreiber S. Tran F, et al. Among authors: schulze forster k. ERJ Open Res. 2022 Dec 27;8(4):00379-2022. doi: 10.1183/23120541.00379-2022. eCollection 2022 Oct. ERJ Open Res. 2022. PMID: 36575710 Free PMC article.
Dysregulated autoantibodies targeting vaso- and immunoregulatory receptors in Post COVID Syndrome correlate with symptom severity.
Sotzny F, Filgueiras IS, Kedor C, Freitag H, Wittke K, Bauer S, Sepúlveda N, Mathias da Fonseca DL, Baiocchi GC, Marques AHC, Kim M, Lange T, Plaça DR, Luebber F, Paulus FM, De Vito R, Jurisica I, Schulze-Forster K, Paul F, Bellmann-Strobl J, Rust R, Hoppmann U, Shoenfeld Y, Riemekasten G, Heidecke H, Cabral-Marques O, Scheibenbogen C. Sotzny F, et al. Among authors: schulze forster k. Front Immunol. 2022 Sep 27;13:981532. doi: 10.3389/fimmu.2022.981532. eCollection 2022. Front Immunol. 2022. PMID: 36238301 Free PMC article.
Soluble (pro)renin receptor in elderly chronic heart failure patients.
Obradovic D, Loncar G, Radenovic S, Tahirovic E, Heidecke H, Schulze-Forster K, Muller D, Busjahn A, Buttner P, Veskovic J, Zdravkovic M, Li H, Li S, Savkovic V, Pieske B, Dungen HD, Dechend R. Obradovic D, et al. Among authors: schulze forster k. Front Biosci (Landmark Ed). 2020 Jun 1;25(10):1839-1853. doi: 10.2741/4880. Front Biosci (Landmark Ed). 2020. PMID: 32472760 Free article.
Stem-cell mobilization of healthy sibling donors with pegfilgrastim-A prospective open-label phase II trial (EudraCT no: 2005-004971-39).
Vucinic V, Jentzsch M, Leiblein S, Bach E, Remane Y, Schulze-Forster K, Cross M, Pönisch W, Schwind S, Franke GN, Platzbecker U, Niederwieser D. Vucinic V, et al. Among authors: schulze forster k. Transfusion. 2022 Jan;62(1):157-164. doi: 10.1111/trf.16761. Epub 2021 Dec 10. Transfusion. 2022. PMID: 34893987 Clinical Trial.
26 results